China has asked some of its state-owned drugmakers to study how they can reduce reliance on the US for pharmaceutical products and raw materials, people familiar with the matter said, as Beijing prepares for a potential decoupling that threatens its medical supply.
Visited 1 times, 1 visit(s) today
